NASDAQ · Health care

OSR Health, Inc. (OSRH)

OSR Health, Inc. brought in $1.8M of revenue over the twelve months to June 30, 2026, down 50.2% from a year earlier. It posted a net loss of $10.7M. At June 30, 2026 it held $1.5M in cash against $544.1K of debt. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 14, 2026.

Watch OSRH in 60 seconds

Revenue (last 12 months)

$1.8M

-50.2% year on year

Net margin

-593.2%

What OSR Health, Inc. does

OSR Health, Inc. is registered with the SEC under industry code SIC 3841 (Surgical & Medical Instruments & Apparatus). Its shares trade on NASDAQ under the ticker OSRH.

Revenue and profit by year

Revenue

Net income

Fiscal years as reported in annual reports. Amounts in USD.

Key figures

Fiscal year	Revenue	Operating income	Net income	Diluted EPS	Free cash flow
2025	$2.9M	-$18.3M	-$18M	-$0.80	n/a
2024	$3.5M	-$11.7M	-$2.4M	-$4.79	n/a
2023	n/a	-$1.8M	$403.8K	$0.44	n/a
2022	n/a	-$35.4K	-$35.4K	-$0.09	n/a
2022	n/a	-$3.3K	-$3.3K	$0.00	n/a

Full financial statements: income, balance sheet and cash flow

Next report expected around November 11, 2026.

Estimated from its filing rhythm: 52 weeks after its report of November 12, 2025. Not a date the company has announced. See the report calendar

Where OSRH ranks in Health care

Revenue$2.9M

#530 of 646 in Health care · Bottom 18%

Latest fiscal year of every company in the sector with the figure reported. Revenue is ranked among companies reporting in US dollars; growth and margins among companies with at least 10 million of revenue. Health care

Latest SEC filings

What OSR Health, Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.

August 28, 2026
Other event 8-K
August 25, 2026
Other event 8-K
August 19, 2026
Stock exchange listing notice 8-K
August 17, 2026
Passive stake changed SCHEDULE 13G/A
August 14, 2026
Quarterly report 10-Q · period to June 30, 2026Revenue fell 72% to $315.7K versus the same quarter last year; diluted EPS -$0.02 versus $0.02.
August 10, 2026
Shareholder vote results 8-K
August 7, 2026
Investor disclosure 8-K
July 31, 2026
Investor disclosure 8-K
July 16, 2026
Proxy statement DEF 14A
July 6, 2026
Preliminary proxy statement PRE 14A

Recent insider filings (Forms 3, 4 and 144): 10, the latest on April 16, 2026. Insider transactions on SEC

Who owns OSRH

Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.

5% holders

Anyone who owns more than 5% of a class of shares must say so on Schedule 13D (if they may seek to influence the company) or 13G (a passive holder). The latest filing of each holder is shown: 13G filings of the last 2 years, 13D of the last 3.

Holder	Of class	Shares	Filed
Bellevue Capital Management LLC13G, passive with 3 related filers	87.7%	2,035,000	February 11, 2025

Latest filings below 5%: joint protein central inc. 3.4% (August 17, 2026); Rivernorth Capital Management, LLC 0% (January 10, 2025).

Largest institutional holders

No Form 13F positions imported for this company yet.

Insiders

Reported holdings of insiders who filed a Form 4 in the last 12 months: the shares each one held after their latest reported transaction. This is not the total held by all insiders.

We have not read this company's Form 4 filings yet.

Schedule 13D/13G filings on SEC.gov

All filings on SEC EDGAR

Questions about OSRH

What does OSR Health, Inc. do?

OSR Health, Inc. is registered with the SEC under industry code SIC 3841 (Surgical & Medical Instruments & Apparatus). Its shares trade on NASDAQ under the ticker OSRH.

Is OSR Health, Inc. profitable?

No. Over the twelve months to June 30, 2026 it reported a net loss of $10.7M on revenue of $1.8M.

How much revenue does OSR Health, Inc. make?

Over the twelve months to June 30, 2026 OSR Health, Inc. reported revenue of $1.8M. That is 50.2% less than a year earlier.

When did OSR Health, Inc. last report?

Its most recent periodic report is the quarterly report (10-Q) filed on August 14, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the other event from August 28, 2026.

Similar companies

Becton Dickinson & Co

BSX

Boston Scientific Corp

BAX

Baxter International Inc

Compare OSRH with

Compare OSRH with any company

Follow OSRH

Get an email when OSR Health, Inc. files with the SEC: results, executive changes, material agreements and annual reports.

Follow OSRH: get an email when it files

Where the numbers come from

Financial figures are the values OSR Health, Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.

Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.